Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.1
13.44
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 12.25 HKD. Compared to the current market price of 8 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Beijing Tong Ren Tang Chinese Medicine Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Balance Sheet Decomposition
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Current Assets | 3.7B |
Cash & Short-Term Investments | 1.8B |
Receivables | 340.9m |
Other Current Assets | 1.6B |
Non-Current Assets | 565.3m |
Long-Term Investments | 53.1m |
PP&E | 437.4m |
Intangibles | 54.7m |
Other Non-Current Assets | 20.1m |
Current Liabilities | 221.1m |
Accounts Payable | 140.5m |
Other Current Liabilities | 80.6m |
Non-Current Liabilities | 250.8m |
Long-Term Debt | 78m |
Other Non-Current Liabilities | 172.9m |
Earnings Waterfall
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Revenue
|
1.4B
HKD
|
Cost of Revenue
|
-384.7m
HKD
|
Gross Profit
|
992m
HKD
|
Operating Expenses
|
-439m
HKD
|
Operating Income
|
553m
HKD
|
Other Expenses
|
-58.9m
HKD
|
Net Income
|
494.1m
HKD
|
Free Cash Flow Analysis
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKD | |
Free Cash Flow | HKD |
Profitability Score
Profitability Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 12.29 HKD with a low forecast of 11.41 HKD and a high forecast of 13.44 HKD.
Dividends
Current shareholder yield for Beijing Tong Ren Tang Chinese Medicine Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Contact
IPO
Employees
Officers
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 12.25 HKD.
Compared to the current market price of 8 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 35%.